morphine sulfate ER Kadian
Selected indexed studies
- Morphine sulfate abuse-deterrent formulations for the treatment of chronic pain. (Expert Rev Clin Pharmacol, 2018) [PMID:30403896]
- Oral hydromorphone extended-release. (Consult Pharm, 2010) [PMID:21172762]
- Morphine-Mediated Brain Region-Specific Astrocytosis Involves the ER Stress-Autophagy Axis. (Mol Neurobiol, 2018) [PMID:29344928]
_Worker-drafted node — pending editorial review._
Connections
morphine sulfate ER Kadian is a side effect of
Sources
- Oral hydromorphone extended-release. (2010) pubmed
- Morphine sulfate abuse-deterrent formulations for the treatment of chronic pain. (2018) pubmed
- Morphine-Mediated Brain Region-Specific Astrocytosis Involves the ER Stress-Autophagy Axis. (2018) pubmed
- Internet-based survey of nonmedical prescription opioid use in the United States. (2008) pubmed
- Tramadol Therapy and CYP2D6 Genotype. (2012) pubmed
- Do abuse deterrent opioid formulations work? (2017) pubmed
- A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine. (2019) pubmed
- Arymo ER--a new abuse-deterrent morphine formulation. (2017) pubmed
- Effects of toxicants on endoplasmic reticulum stress and hepatic cell fate determination. (2023) pubmed
- Opioid receptor heteromers in analgesia. (2012) pubmed